Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lillian S L Ting"'
Autor:
Mary H H Ensom, Chantal Guillemette, Olivier Bernard, Marie-Odile Benoit-Biancamano, K. Wayne Riggs, Lillian S L Ting
Publikováno v:
Pharmacotherapy. 30:1097-1108
Study Objective. To assess the contribution of polymorphisms in the uridine diphosphate glucuronosyltransferase gene (UGT) and the multidrug resistance-associated protein 2 gene (ABCC2) to mycophenolic acid (MPA) pharmacokinetics and clinical outcome
Autor:
Nilufar Partovi, Lillian S L Ting, Mai Al-Khatib, Marc Levine, R. Jean Shapiro, Mary H H Ensom
Publikováno v:
Annals of Pharmacotherapy. 44:19-27
Mycophenolate mofetil is widely used in islet transplant recipients and its active metabolite, mycophenolic acid (MPA), exhibits wide pharmacokinetic variability. However, to our knowledge, no limited sampling strategy (LSS) exists for monitoring MPA
Publikováno v:
Therapeutic Drug Monitoring. 30:282-291
Mycophenolate mofetil is an immunosuppressant commonly used in solid organ transplantation. Its active metabolite, mycophenolic acid (MPA), is metabolized to the inactive 7-O-mycophenolic acid glucuronide (MPAG) and the active acyl glucuronide (AcMPA
Publikováno v:
Annals of Pharmacotherapy. 40:1509-1516
Background: Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil, an immunosuppressive agent commonly used in solid organ transplantation. MPA is metabolized to the inactive metabolite 7-O-mycophenolic acid glucuronide (MPAG) and
Publikováno v:
Pharmacotherapy. 26:1232-1240
Study Objective. To develop limited sampling strategies for estimation of mycophenolic acid exposure (by determining area under the concentration-time curve [AUC]) in lung transplant recipients by using sampling times within 2 hours after drug admini
Beyond Cyclosporine: A Systematic Review of Limited Sampling Strategies for Other Immunosuppressants
Publikováno v:
Therapeutic Drug Monitoring. 28:419-430
Therapeutic drug monitoring has gained much attention in the management of immunosuppressive therapy. Area under the plasma drug concentration-time curve (AUC) is the pharmacokinetic (PK) parameter most commonly used to assess total exposure to a dru
Publikováno v:
Therapeutic drug monitoring. 32(3)
Given the paucity of data on pharmacokinetics of mycophenolic acid (MPA) in islet transplant, the aim of this study was to characterize pharmacokinetic parameters of MPA and its 2 glucuronidated metabolites in stable islet transplant recipients. Sixt
Publikováno v:
The Annals of pharmacotherapy. 42(7)
To review the current clinical evidence on the effects of corticosteroid interactions with the immunosuppressive drugs cyclosporine, tacrolimus, mycophenolate, and sirolimus.Articles were retrieved through MEDLINE (1966-February 2008) using the terms
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 27(3)
Background and Methods Eight limited sampling strategies (LSSs) for estimating mycophenolic acid area under the concentration–time curve (4 developed from lung transplant recipients at our center, 4 developed for heart transplant recipients from ot
Publikováno v:
Clinical pharmacokinetics. 46(6)
Despite evidence in the literature suggesting that a strong correlation exists between the pharmacokinetic parameters and pharmacodynamic effect of anticancer agents, many of these agents are still dosed by body surface area. Therapeutic drug monitor